Package 63850-0058-4

{"route": ["ORAL"], "spl_id": "6df3819e-2d45-4030-a4af-6caeccb8a471", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0363850006128", "0363850005817", "0363850006111", "0363850005923", "0363850005824", "0363850005916", "0363850006012"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_set_id": ["e3dbbc24-7e55-4069-a305-e2cded2db641"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Natco Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (63850-0058-1)  / 7 TABLET in 1 BLISTER PACK", "package_ndc": "63850-0058-1", "marketing_start_date": "20210305"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (63850-0058-4)", "package_ndc": "63850-0058-4", "marketing_start_date": "20230526"}], "brand_name": "Everolimus", "product_id": "63850-0058_6df3819e-2d45-4030-a4af-6caeccb8a471", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "63850-0058", "generic_name": "Everolimus", "labeler_name": "Natco Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "2.5 mg/1"}], "application_number": "ANDA205426", "marketing_category": "ANDA", "marketing_start_date": "20210305", "listing_expiration_date": "20261231"}